Claritev Plunges on Disappointing 2026 Outlook

Dow Jones02-25

By Elias Schisgall

Claritev shares plunged after the company's 2026 outlook for revenue and adjusted earnings disappointed Wall Street investors.

Shares fell 37% to $14.67 in midday Tuesday trading. The stock has fallen 80% over the past six months.

The healthcare technology company on Monday reported a loss of $80.6 million, or $4.88 a share, compared with a loss of about $138 million, or $8.53 a share, in the year-ago period.

Revenue rose to $246.6 million, up from $232.1 million a year prior. Analysts were expecting $241 million in revenue.

For the current year, the company said it expects revenue between $980 million and $1 billion and adjusted earnings before interest, taxes, depreciation, and amortization of between $605 million and $615 million.

Analysts were expecting revenue of $996.1 million and adjusted Ebitda of $620.8 million as of late January, prior to the earnings release.

Write to Elias Schisgall at elias.schisgall@wsj.com

(END) Dow Jones Newswires

February 24, 2026 11:51 ET (16:51 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2614074695?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-25 00:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2614074695","market":"other","top_or_hot":-1,"title":"Claritev Plunges on Disappointing 2026 Outlook","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Elias Schisgall \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Claritev shares plunged after the company's 2026 outlook for revenue and adjusted earnings disappointed Wall Street investors. \n</p>\n<p>\n  Shares fell 37% to $14.67 in midday Tuesday trading. The stock has fallen 80% over the past six months. \n</p>\n<p>\n  The healthcare technology company on Monday reported a loss of $80.6 million, or $4.88 a share, compared with a loss of about $138 million, or $8.53 a share, in the year-ago period. \n</p>\n<p>\n  Revenue rose to $246.6 million, up from $232.1 million a year prior. Analysts were expecting $241 million in revenue. \n</p>\n<p>\n  For the current year, the company said it expects revenue between $980 million and $1 billion and adjusted earnings before interest, taxes, depreciation, and amortization of between $605 million and $615 million. \n</p>\n<p>\n  Analysts were expecting revenue of $996.1 million and adjusted Ebitda of $620.8 million as of late January, prior to the earnings release. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 24, 2026 11:51 ET (16:51 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Claritev Plunges on Disappointing 2026 Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nClaritev Plunges on Disappointing 2026 Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-02-25 00:51</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Elias Schisgall \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Claritev shares plunged after the company's 2026 outlook for revenue and adjusted earnings disappointed Wall Street investors. \n</p>\n<p>\n  Shares fell 37% to $14.67 in midday Tuesday trading. The stock has fallen 80% over the past six months. \n</p>\n<p>\n  The healthcare technology company on Monday reported a loss of $80.6 million, or $4.88 a share, compared with a loss of about $138 million, or $8.53 a share, in the year-ago period. \n</p>\n<p>\n  Revenue rose to $246.6 million, up from $232.1 million a year prior. Analysts were expecting $241 million in revenue. \n</p>\n<p>\n  For the current year, the company said it expects revenue between $980 million and $1 billion and adjusted earnings before interest, taxes, depreciation, and amortization of between $605 million and $615 million. \n</p>\n<p>\n  Analysts were expecting revenue of $996.1 million and adjusted Ebitda of $620.8 million as of late January, prior to the earnings release. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 24, 2026 11:51 ET (16:51 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4167","symbol_name":"医疗保健技术","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2614074695","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2614074695","pubTimestamp":1771951860,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Claritev shares plunged after the company's 2026 outlook for revenue and adjusted earnings disappointed Wall Street investors.Shares fell 37% to $14.67 in midday Tuesday trading. The stock has fallen 80% over the past six months.The healthcare technology company on Monday reported a loss of $80.6 million, or $4.88 a share, compared with a loss of about $138 million, or $8.53 a share, in the year-ago period.Revenue rose to $246.6 million, up from $232.1 million a year prior. Analysts were expecting $241 million in revenue.For the current year, the company said it expects revenue between $980 million and $1 billion and adjusted earnings before interest, taxes, depreciation, and amortization of between $605 million and $615 million.Analysts were expecting revenue of $996.1 million and adjusted Ebitda of $620.8 million as of late January, prior to the earnings release.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4167":"医疗保健技术","CTEV":"Claritev Corporation"},"translate_title":"Claritev因2026年前景令人失望而暴跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CTEV":0.9},"content_text":"By Elias Schisgall \n\n\n \n\n\n  Claritev shares plunged after the company's 2026 outlook for revenue and adjusted earnings disappointed Wall Street investors. \n\n\n  Shares fell 37% to $14.67 in midday Tuesday trading. The stock has fallen 80% over the past six months. \n\n\n  The healthcare technology company on Monday reported a loss of $80.6 million, or $4.88 a share, compared with a loss of about $138 million, or $8.53 a share, in the year-ago period. \n\n\n  Revenue rose to $246.6 million, up from $232.1 million a year prior. Analysts were expecting $241 million in revenue. \n\n\n  For the current year, the company said it expects revenue between $980 million and $1 billion and adjusted earnings before interest, taxes, depreciation, and amortization of between $605 million and $615 million. \n\n\n  Analysts were expecting revenue of $996.1 million and adjusted Ebitda of $620.8 million as of late January, prior to the earnings release. \n\n\n \n\n\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 24, 2026 11:51 ET (16:51 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2614074695","isCrawlerRequest":true}